During the past decade, Triangle Urological Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Triangle Urological Group" #1 sponsor was "Bioniche Life Sciences Inc." with 2 trials, followed by "Christopher Sweeney, MBBS" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored, "PRAECIS Pharmaceuticals Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Triangle Urological Group" #1 collaborator was "Hoosier Cancer Research Network" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Walther Cancer Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Triangle Urological Group" are "Prostate Cancer" (2 trials), "Bladder Cancer" (1 trials), "Bladder Neoplasm" (1 trials), "Bladder Neoplasms" (1 trials) and "Carcinoma in Situ" (1 trials). Many other conditions were trialed in "Triangle Urological Group" in a lesser frequency.

Most popular intervention types in "Triangle Urological Group" are "Drug" (6 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (1 trials), "EN3348" (1 trials), "Fesoterodine 4mg" (1 trials) and "Fesoterodine 8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Triangle Urological Group" are 4 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Triangle Urological Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Triangle Urological Group, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Triangle Urological Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".